ABOUT PHARNEXT

Pharnext is the pioneer of a new R&D paradigm synergizing Pharma, Nutrition and Wellness. This approach, incubated by seasoned founders over 30 years, is applicable to virtually any human characteristic or trait (e.g. disease, ageing, aesthetics) and offers global care solutions integrating safe drugs and natural substances.

MAJOR ACHIEVEMENTS

Since inception in 2007, Pharnext has successfully raised €50m financing, including €30m from high quality shareholders. Five major experimental programs are already in clinical development for neurodegenerative and metabolic diseases.

Investors

donatorsWould you be interested in investing in Pharnext ?

ABOUT PLEOTREATMENTS

Pharnext approach is based on a unique set of proprietary technologies: network biology, repurposing of existing products in low-dose combinations and biomarker discovery. To learn more about Pharnext and pleotreatmentsTM, watch our video!

SHOW IN WINDOW